# Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients

> **NCT01198379** · PHASE4 · WITHDRAWN · sponsor: **Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation**

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **DRUG:** aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01198379
- **Lead sponsor:** Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-02
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-01-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2019-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198379, "Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01198379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*